• LAST PRICE
    53.2700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    50.0000/ 1
  • Ask / Lots
    56.7000/ 6
  • Open / Previous Close
    0.0000 / 53.2700
  • Day Range
    ---
  • 52 Week Range
    Low 30.7400
    High 75.1000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 54.36
TimeVolumeACLX
09:32 ET239654.36
09:36 ET50054.445
09:38 ET40054.7
09:39 ET20054.425
09:41 ET20054.74
09:43 ET10054.775
09:45 ET40054.76
09:48 ET200054.88
09:50 ET79754.87
09:52 ET120055
09:54 ET299255.08
09:56 ET539354.97
09:57 ET90054.83
09:59 ET70054.91
10:01 ET548055.015
10:03 ET20055.13
10:06 ET60055.19
10:08 ET83955.115
10:10 ET33455.16
10:12 ET120955.33
10:14 ET30055.37
10:15 ET161955.365
10:17 ET467954.84
10:19 ET30054.94
10:21 ET30054.88
10:24 ET10054.8
10:26 ET110055.215
10:28 ET120655.2
10:30 ET20055.11
10:32 ET10055.02
10:33 ET20055.12
10:35 ET20055.17
10:37 ET160554.84
10:42 ET30054.43
10:44 ET220054.2016
10:46 ET75354.2
10:48 ET143054.325
10:51 ET100054.43
10:53 ET10054.29
10:55 ET93754.455
10:57 ET841254.42
11:00 ET20054.55
11:02 ET20054.505
11:04 ET20054.605
11:06 ET40054.54
11:08 ET50054.56
11:09 ET268354.72
11:13 ET24854.74
11:15 ET20054.78
11:18 ET10054.75
11:20 ET20054.7825
11:22 ET20054.775
11:24 ET30054.86
11:26 ET34754.76
11:27 ET200054.77
11:31 ET43054.705
11:33 ET20154.79
11:36 ET20054.78
11:38 ET1143654.28
11:40 ET255954.22
11:42 ET246954.635
11:44 ET93454.555
11:45 ET280054.53
11:49 ET20054.5
11:51 ET10054.41
11:54 ET50054.43
12:02 ET60054.44
12:03 ET353054.7
12:05 ET40054.61
12:09 ET80054.59
12:12 ET40454.62
12:16 ET80054.505
12:18 ET20054.515
12:21 ET40054.425
12:23 ET50054.33
12:30 ET40054.365
12:32 ET76354.435
12:34 ET150054.29
12:36 ET50054.15
12:38 ET80254.25
12:48 ET70054.1925
12:52 ET10054.185
12:54 ET230053.94
12:56 ET40053.885
12:57 ET246253.99
01:01 ET100954.13
01:06 ET291953.92
01:10 ET727553.735
01:12 ET2673053.65
01:15 ET50053.6133
01:17 ET20053.65
01:21 ET2815853.445
01:24 ET126653.3
01:26 ET1494253.395
01:28 ET10053.43
01:30 ET20053.47
01:33 ET186053.345
01:37 ET20053.35
01:39 ET231153.41
01:44 ET323053.44
01:46 ET60053.44
01:48 ET30053.44
01:50 ET10053.445
01:51 ET214053.42
01:53 ET50053.45
01:57 ET3005053.41
02:00 ET110053.41
02:02 ET33053.35
02:06 ET30153.395
02:08 ET40053.4
02:09 ET213053.37
02:11 ET10053.38
02:13 ET10053.35
02:15 ET70053.34
02:18 ET140053.06
02:20 ET430253.1
02:22 ET253753.41
02:24 ET20053.39
02:26 ET67553.29
02:29 ET10053.32
02:31 ET40053.375
02:33 ET251153.24
02:36 ET160053.165
02:38 ET31953.135
02:40 ET89653.135
02:42 ET302253.18
02:45 ET113153.15
02:47 ET40053.15
02:49 ET331653.15
02:51 ET105853.15
02:54 ET251053.24
02:56 ET80053.2
02:58 ET110953.24
03:00 ET20053.28
03:02 ET40053.27
03:03 ET50053.2
03:05 ET38553.22
03:07 ET174953.35
03:09 ET30053.4125
03:12 ET102553.38
03:14 ET529853.59
03:16 ET60053.55
03:20 ET10053.6
03:21 ET199353.51
03:23 ET20053.495
03:25 ET449853.3
03:27 ET149853.42
03:30 ET55053.36
03:32 ET51253.335
03:34 ET40053.3
03:36 ET10053.305
03:38 ET90053.355
03:39 ET199753.35
03:41 ET60053.34
03:43 ET20053.335
03:45 ET61053.33
03:48 ET150253.3
03:50 ET153153.31
03:52 ET539953.31
03:54 ET1101253.425
03:56 ET2394253.295
03:57 ET454753.18
03:59 ET7432853.27
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACLX
Arcellx Inc
2.9B
-51.3x
---
United StatesRNA
Avidity Biosciences Inc
2.8B
-10.0x
---
United StatesARVN
Arvinas Inc
2.4B
-5.7x
---
United StatesDYN
Dyne Therapeutics Inc
2.9B
-8.2x
---
United StatesMRUS
Merus NV
2.6B
-16.1x
---
United StatesAPGE
Apogee Therapeutics Inc
2.9B
-24.1x
---
As of 2024-05-22

Company Information

Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).

Contact Information

Headquarters
800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
Phone
240-327-0603
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Rami Elghandour
Chief Financial Officer
Michelle Gilson
Chief Medical Officer
Christopher Heery
Independent Director
Ali Behbahani
Independent Director
Jill Carroll

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.9B
Revenue (TTM)
$131.7M
Shares Outstanding
53.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.04
Book Value
$9.28
P/E Ratio
-51.3x
Price/Sales (TTM)
21.6
Price/Cash Flow (TTM)
---
Operating Margin
-57.14%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.